Erowid References Database
|
Hockenhull J, Murphy KG, Paterson S.
“Mephedrone use is increasing in London”.
Lancet. 2016 Apr 26;387(10029):1719-1720.
|
|
Abstract
[Excerpt] Anecdotal evidence suggests that mephedrone is rarely used in the USA or Europe as a whole. However, there has been a strong increase in the number of people presenting for mephedrone treatment in England,[3] and mephedrone is regularly detected in post-mortem samples analysed at the Toxicology Unit, Imperial College London, from coroners' jurisdictions across London and southeast England. The number of deaths in which mephedrone was detected in 2015 (n=34, 1.5% of total cases received) has increased since 2014 (n=22, 1.0%). The number of deaths associated with mephedrone is comparable to the number of deaths in which methylenedioxymethyl-amphetamine (MDMA), an established recreational drug, was detected (n=28, 1.2% of total cases in 2015 and n=25, 1.1% in 2014).
|
| # |
| Submit Comment |
|
[
Cite HTML ]
